Literature DB >> 21606603

Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link?

David S Wilkes1.   

Abstract

Chronic lung allograft rejection, known as obliterative bronchiolitis (OB), is the leading cause of death in lung transplant patients. Although OB pathogenesis is not fully understood, in this issue of the JCI, Jiang and colleagues report that tissue hypoxia resulting in dysfunctional airway microvasculature precedes the airway fibrosis characteristic of OB. In addition, a relative deficiency of allograft endothelial cell-derived HIF-1α contributes to this process. Data showing that overexpressing HIF-1α restores the microvascular airway normoxia and prevents airway fibrosis highlight a novel role for vascular biology in OB pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606603      PMCID: PMC3104786          DOI: 10.1172/JCI58329

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ.

Authors:  Stephanie L Constant; Jennifer L Brogdon; Damani A Piggott; Christina A Herrick; Irene Visintin; Nancy H Ruddle; Kim Bottomly
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Bronchial artery revascularization restores peribronchial tissue oxygenation after lung transplantation.

Authors:  Markus Kamler; Kai Nowak; Matthias Bock; Ulf Herold; Johann Motsch; Siegfried Hagl; Martha Maria Gebhard; Heinz Jakob
Journal:  J Heart Lung Transplant       Date:  2004-06       Impact factor: 10.247

Review 3.  Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness.

Authors:  S M Studer; R D Levy; K McNeil; J B Orens
Journal:  Eur Respir J       Date:  2004-10       Impact factor: 16.671

4.  Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients.

Authors:  C Ward; I A Forrest; D M Murphy; G E Johnson; H Robertson; T E Cawston; A J Fisher; J H Dark; J L Lordan; J A Kirby; P A Corris
Journal:  Thorax       Date:  2005-06-21       Impact factor: 9.139

5.  Microvascular destruction identifies murine allografts that cannot be rescued from airway fibrosis.

Authors:  Ashok N Babu; Tomohiro Murakawa; Joshua M Thurman; Edmund J Miller; Peter M Henson; Martin R Zamora; Norbert F Voelkel; Mark R Nicolls
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?

Authors:  Heyman Luckraz; Martin Goddard; Keith McNeil; Carl Atkinson; Linda D Sharples; John Wallwork
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

7.  Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection.

Authors:  Xinguo Jiang; Mohammad A Khan; Wen Tian; Joshua Beilke; Ramesh Natarajan; Jon Kosek; Mervin C Yoder; Gregg L Semenza; Mark R Nicolls
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

8.  Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation.

Authors:  Heyman Luckraz; Martin Goddard; Keith McNeil; Carl Atkinson; Susan C Charman; Susan Stewart; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2004-05       Impact factor: 10.247

9.  Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Joseph P Lynch; Ying Ying Xue; Kewang Li; David J Ross; Robert M Strieter
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

10.  IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Authors:  William J Burlingham; Robert B Love; Ewa Jankowska-Gan; Lynn D Haynes; Qingyong Xu; Joseph L Bobadilla; Keith C Meyer; Mary S Hayney; Ruedi K Braun; Daniel S Greenspan; Bagavathi Gopalakrishnan; Junchao Cai; David D Brand; Shigetoshi Yoshida; Oscar W Cummings; David S Wilkes
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more
  13 in total

1.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

Review 2.  Hypoxia-inducible factors in physiology and medicine.

Authors:  Gregg L Semenza
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

3.  Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.

Authors:  Bryan D Kraft; Hagir B Suliman; Eli C Colman; Kamran Mahmood; Matthew G Hartwig; Claude A Piantadosi; Scott L Shofer
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

4.  Hypoxia-Inducible Factor-1α Regulates CD55 in Airway Epithelium.

Authors:  Pankita H Pandya; Amanda J Fisher; Elizabeth A Mickler; Constance J Temm; Kelsey P Lipking; Adam Gracon; Katia Rothhaar; George E Sandusky; Mary Murray; Karen Pollok; Jamie Renbarger; Janice S Blum; Tim Lahm; David S Wilkes
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

5.  Airway hypoxia in lung transplantation.

Authors:  Shravani Pasnupneti; Mark R Nicolls
Journal:  Curr Opin Physiol       Date:  2018-12-13

6.  Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction.

Authors:  Emily K Glover; Nina Jordan; Neil S Sheerin; Simi Ali
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

7.  Hypoxia and hypoxia mimetics inhibit TNF-dependent VCAM1 induction in the 5A32 endothelial cell line via a hypoxia inducible factor dependent mechanism.

Authors:  Todd V Cartee; Kellie J White; Marvin Newton-West; Robert A Swerlick
Journal:  J Dermatol Sci       Date:  2011-10-19       Impact factor: 4.563

8.  IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.

Authors:  Ragini Vittal; Lin Fan; Daniel S Greenspan; Elizabeth A Mickler; Bagavathi Gopalakrishnan; Hongmei Gu; Heather L Benson; Chen Zhang; William Burlingham; Oscar W Cummings; David S Wilkes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-21       Impact factor: 5.464

Review 9.  Targeting hypoxia-inducible factor 1 to stimulate tissue vascularization.

Authors:  Gregg L Semenza
Journal:  J Investig Med       Date:  2016-01-11       Impact factor: 2.895

10.  IL-10 Mediated Immunomodulation Limits Subepithelial Fibrosis and Repairs Airway Epithelium in Rejecting Airway Allografts.

Authors:  Mohammad Afzal Khan; Ghazi Abdulmalik Ashoor; Talal Shamma; Fatimah Alanazi; Abdullah Altuhami; Shadab Kazmi; Hala Abdalrahman Ahmed; Abdullah Mohammed Assiri; Dieter Clemens Broering
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.